Drug intelligence / Profile preview

VINSUVET

Development stage
Unknown
Lead developer
Medsintez
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous
01

Overview

VINSUVET is a brand of veterinary recombinant protein products developed and manufactured by the Medsintez Plant (Zavod Medsintez) in Russia. The product line is specifically designed for use in companion animals, such as dogs and cats, and includes several biosimilar formulations of human proteins adapted for veterinary medicine. The brand encompasses multiple distinct products: **VINSUVET Glargine**, a long-acting insulin analogue for the treatment of diabetes mellitus; **VINSUVET Mix 30/70**, a biphasic insulin preparation consisting of 30% soluble insulin and 70% isophane insulin; and **VINSUVET FSH**, a recombinant follicle-stimulating hormone used to manage reproductive disorders and stimulate follicular growth. These products provide high-purity, recombinant alternatives to traditional animal-derived or human-labeled medications for veterinary practitioners.

Brand names
VINSUVETVINSUVET-FSHVINSUVET GlargineVINSUVET mix 30/70
Other names
VINSUVET 30/70 insulin mix
02

Targets

INSR (Insulin receptor)IGF-1R (Insulin-like growth factor 1 receptor)

Beyond the preview

Go deeper on VINSUVET.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VINSUVET.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call